目的观察益气温经方联合新编五禽戏的综合疗法对绝经后骨量减低患者的临床疗效。方法将120例绝经后骨量减低患者随机分为治疗组和对照组,每组60例。对照组患者予日光浴和饮食干预。治疗组患者在对照组的基础上予益气温经方联合新编五禽...目的观察益气温经方联合新编五禽戏的综合疗法对绝经后骨量减低患者的临床疗效。方法将120例绝经后骨量减低患者随机分为治疗组和对照组,每组60例。对照组患者予日光浴和饮食干预。治疗组患者在对照组的基础上予益气温经方联合新编五禽戏的综合疗法进行干预治疗。观察周期为12个月。观察两组患者治疗前、治疗6个月后、12个月后的腰椎骨密度(bone mineral denisty,BMD)、SF-36生活质量(SF-36 quality of life score,SF-36)评分,并统计治疗结束后两组患者骨质疏松症发生率。结果腰椎骨密度:治疗前,两组患者腰椎骨密度之间差异无统计学意义(P>0.05);治疗后,治疗组患者腰椎骨密度逐渐升高,对照组患者腰椎骨密度呈下降趋势,治疗组与对照组患者治疗6个月后及治疗12个月后,两组腰椎骨密度值之间差异有统计学意义(P<0.05);(2)骨质疏松发生率:治疗12个月后,治疗组有5例(10.0%)患者继发为骨质疏松症,对照组有13例(25.0%)患者继发为骨质疏松症,两组差异有统计学意义(P<0.05)。(3)SF-36生活质量评分:治疗前2组患者生活质量评分比较无统计学意义(P>0.05)。治疗12个月后,治疗组患者的生活质量评分明显高于对照组,两组差异有统计学意义(P<0.05)。结论益气温经方联合新编五禽戏的综合疗法能够改善绝经后骨量减低患者生活质量,提升骨密度,降低骨质疏松的发生率,值得临床借鉴和应用。展开更多
Objective: To investigate the serum protein targets of Qianggu Decoction(强骨饮, QGD) on treating osteoporosis by the proteomics analysis using tandem mass tag(TMT) and liquid chromatographytandem mass spectrome...Objective: To investigate the serum protein targets of Qianggu Decoction(强骨饮, QGD) on treating osteoporosis by the proteomics analysis using tandem mass tag(TMT) and liquid chromatographytandem mass spectrometry(LC-MS/MS). Methods: Twenty serum protein samples were recruited(10 patients with primary type Ⅰ osteoporosis before and after QGD treatment) and the high abundance ratios protein was removed, two serum samples were extracted and labeled with TMT reagent. Then, mass spectrometric detection, identification of differentially expressed proteins and bioinformatics analysis of differentially expressed proteins were carried out. Results: A total of 60 proteins were identified, within a 99% confidence interval, to be differentially regulated of which, 34 proteins were up-regulated and 26 proteins were down-regulated. Differentially expressed proteins analyzed by Gene Ontology(GO) annotation mainly get involved in 12 different biological processes, 7 types of cellular components, and 6 kinds of molecular functions. Angiotensinogen(AGT), stromelysin-1(MMP3), heparanase(HPSE) and glyceraldehyde-3-phosphate dehydrogenase(GAPDH) were screened as candidate protein targets of QGD treatment, which were related to metabolic mechanism of bone remodeling and/or bone collagen of osteoporosis. By the utilization of the protein-protein interaction network analysis tool named STRING10.0, it showed that AGT, MMP3, HPSE and GAPDH were located in the key node of the protein-protein interactions network. Furthermore, AGT, MMP3, HPSE and GAPDH were found to be directly related to BMP, MAPK, Wnt, SMAD and tumor necrosis factor ligand superfamily member 11(TNFSF11) families. Conclusions: The proteomics analysis by using TMT combined with LC-MS/MS was a feasible method for screening the potential therapeutic targets associated with QGD treatment. It suggests that AGT, MMP3, HPSE and GAPDH may be candidate protein targets of QGD treatment which can be used as therapeutic effect monitor and early diagnosis of primary type Ⅰ osteoporosis.展开更多
文摘目的观察益气温经方联合新编五禽戏的综合疗法对绝经后骨量减低患者的临床疗效。方法将120例绝经后骨量减低患者随机分为治疗组和对照组,每组60例。对照组患者予日光浴和饮食干预。治疗组患者在对照组的基础上予益气温经方联合新编五禽戏的综合疗法进行干预治疗。观察周期为12个月。观察两组患者治疗前、治疗6个月后、12个月后的腰椎骨密度(bone mineral denisty,BMD)、SF-36生活质量(SF-36 quality of life score,SF-36)评分,并统计治疗结束后两组患者骨质疏松症发生率。结果腰椎骨密度:治疗前,两组患者腰椎骨密度之间差异无统计学意义(P>0.05);治疗后,治疗组患者腰椎骨密度逐渐升高,对照组患者腰椎骨密度呈下降趋势,治疗组与对照组患者治疗6个月后及治疗12个月后,两组腰椎骨密度值之间差异有统计学意义(P<0.05);(2)骨质疏松发生率:治疗12个月后,治疗组有5例(10.0%)患者继发为骨质疏松症,对照组有13例(25.0%)患者继发为骨质疏松症,两组差异有统计学意义(P<0.05)。(3)SF-36生活质量评分:治疗前2组患者生活质量评分比较无统计学意义(P>0.05)。治疗12个月后,治疗组患者的生活质量评分明显高于对照组,两组差异有统计学意义(P<0.05)。结论益气温经方联合新编五禽戏的综合疗法能够改善绝经后骨量减低患者生活质量,提升骨密度,降低骨质疏松的发生率,值得临床借鉴和应用。
基金Supported by the National Natural Science Foundation of China(No.81373878)Natural Science Foundation of Zhejiang Province,China(No.LY13H290009 and No.LY12H29007)
文摘Objective: To investigate the serum protein targets of Qianggu Decoction(强骨饮, QGD) on treating osteoporosis by the proteomics analysis using tandem mass tag(TMT) and liquid chromatographytandem mass spectrometry(LC-MS/MS). Methods: Twenty serum protein samples were recruited(10 patients with primary type Ⅰ osteoporosis before and after QGD treatment) and the high abundance ratios protein was removed, two serum samples were extracted and labeled with TMT reagent. Then, mass spectrometric detection, identification of differentially expressed proteins and bioinformatics analysis of differentially expressed proteins were carried out. Results: A total of 60 proteins were identified, within a 99% confidence interval, to be differentially regulated of which, 34 proteins were up-regulated and 26 proteins were down-regulated. Differentially expressed proteins analyzed by Gene Ontology(GO) annotation mainly get involved in 12 different biological processes, 7 types of cellular components, and 6 kinds of molecular functions. Angiotensinogen(AGT), stromelysin-1(MMP3), heparanase(HPSE) and glyceraldehyde-3-phosphate dehydrogenase(GAPDH) were screened as candidate protein targets of QGD treatment, which were related to metabolic mechanism of bone remodeling and/or bone collagen of osteoporosis. By the utilization of the protein-protein interaction network analysis tool named STRING10.0, it showed that AGT, MMP3, HPSE and GAPDH were located in the key node of the protein-protein interactions network. Furthermore, AGT, MMP3, HPSE and GAPDH were found to be directly related to BMP, MAPK, Wnt, SMAD and tumor necrosis factor ligand superfamily member 11(TNFSF11) families. Conclusions: The proteomics analysis by using TMT combined with LC-MS/MS was a feasible method for screening the potential therapeutic targets associated with QGD treatment. It suggests that AGT, MMP3, HPSE and GAPDH may be candidate protein targets of QGD treatment which can be used as therapeutic effect monitor and early diagnosis of primary type Ⅰ osteoporosis.